[1]
C. Altomare, BS, E. R. Kinzler, PhD, A. R. Buchhalter, PhD, E. J. Cone, PhD, and A. Costantino, PhD, “Laboratory-based testing to evaluate abuse-deterrent formulations and satisfy the Food and Drug Administration’s recommendation for Category 1 Testing”, J of Opioid Management, vol. 13, no. 6, pp. 441–448, Dec. 2017.